Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs;Evaluación neuropsicológica en 129 pacientes chilenos con esclerosis múltiple recurrente remitente previo a inicio de fármacos inmunomoduladores

Revista Medica de Chile

Volumn 140, Issue 11, 2012, Pages 1437-1444

  Nogales Gaete, Jorge ^a,b   Aracena, Rodrigo ^a,b   Díaz, Vannia ^a   Zitko, Pedro ^c   Eloiza, Claudio ^a   Cepeda Zumaeta, Sergio ^a   Agurto, Paula ^a   González, Carola ^a  

^a Unidad de Neurología Cognitiva y Demencias   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Unidad de Estudios Asistenciales   (Chile)

Author keywords

Cognition; Multiple sclerosis; Neuropsychology

Indexed keywords

IMMUNOLOGIC FACTOR;

ADOLESCENT; ADULT; ANXIETY; CASE CONTROL STUDY; CHILD; CHILE; COGNITIVE DEFECT; DEPRESSION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; REVIEW;

ADOLESCENT; ADULT; ANXIETY; CASE-CONTROL STUDIES; CHILD; CHILE; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84877614209     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872012001100009     Document Type: Review

References (37)

1. Compston A, Coles A. Multiple Sclerosis. Lancet 2002; 359 (9313): 1221-31.
2. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis II. Impact on employment and social functioning. Neurology 1991; 41 (5): 692-6.
3. Prakash RS, Snook EM, Lewis JM, Motl RW, Kramer AF. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis. Mult Scler 2008; 14 (9): 1250-61.
4. Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol 1995; 8 (3): 216-20.
5. Jongen PJ, Ter Horst AT, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Med 2012; 103 (2): 73-96.
6. Rodrigues DN, Paes RA, Vasconselos CC, Landeira-Fernández J, Alvarenga MP. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive mukltiple sclerosis. Arq Neuropsiquiatry 2011; 69 (4): 590-5.
7. Beatty WW, Goodkin DE. Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Arch Neurol 1990; 47 (3): 297-301.
8. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41 (5): 685-91.
9. Boringa JB, Lazeron RH, Reuling IE, Adèr HJ, Pfennings L, Lindeboom J, et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001; 7 (4): 263-7.
10. Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003; 74 (4): 443-6.
11. Nogales-Gaete J, Aracena R, Agurto P, Cepeda S, Figueroa C, González C, et al. Programa piloto para pacientes beneficiarios de FONASA, que padecen Esclerosis Múltiple. Tratamiento con Inmunomoduladores en el Sistema Público de Salud de Chile. Informe del primer año, 10 de julio 2008-30 de junio 2009. Rev Chil Neuro-Psiquiat 2010; 48: 9-92.
12. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005; 58 (6): 840-6.
13. Ramos-Brieva JA, Cordero Villafáfila A. En Hernández R, Sandoval G, Cáceres F, Garcea O, Villoslada P. Validación de la versión castellana de la escala de Hamilton para la depresión. Actas Luso-Esp Neurol Psiquiatr 1986; 14: 324-34.
14. Cáceres F, Vanotti S, Rao S; RECONEM Workgroup. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country. J Clin Exp Neuropsychol 2011; 33 (10): 1094-8. Epub 2011 Oct 6.
15. Sepulcre J, Vanotti S, Hernández R, Sandoval G, Cáceres F, Garcea O, et al. Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test. Mult Scler 2006; 12 (2): 187-95.
16. Vizcarra-Escobar D, Cava-Prado L, Tipismana-Barbarán M. Esclerosis múltiple en Perú. Descripción clinicoepidemiológica de una serie de pacientes. Rev Neurol 2005; 41 (10): 591-5.
17. Cardoso E, Fukuda T, Pereira J, Seixas J, Miranda R, Rodrigues B, et al. Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil. Arq Neuropsiquiatr 2006; 64 (3B): 727-30.
18. Fragoso YD, Fiore AP. Description and characteristics of 81 patients attending the Reference Center for Multiple Sclerosis of the coastal region of the state of São Paulo-Brazil. Arq Neuropsiquiatr 2005; 63: 741-4.
19. Nieto Barco A, Sánchez López M, Barroso Ribal J, Olivares Pérez T, Hernández Pérez MA. Alteraciones cognitivas en etapas iniciales de la esclerosis múltiple y su relación con el estado de ánimo, variables demográficas y clínicas. Psicothema 2008; 20 (4): 583-8.
20. Dujardin K, Sockeel P, Cabaret M, De Sèze J, Vermersch P. [BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis]. Rev Neurol (Paris) 2004; 160 (1): 51-62.
21. Siepman TA, Janssens AC, de Koning I, Polman CH, Boringa JB, Hintzen RQ. The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis. J Neurol 2008; 255 (6): 910-6.
22. Deloire M, Ruet A, Hamel D, Bonnet M, Brochet B. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler 2010; 16 (5): 581-7.
23. Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, et al; COGIMUS Study Group. Cognitive impairment and its relation with disease measure in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15 (7): 779-88.
24. Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, et al. The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12 (6):787-93.
25. Portaccio E, Goretti B, Zipoli V, Siracusa G, Sorbi S, Amato MP. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuropsychol 2009; 23 (2): 268-75.
26. Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni M, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis J Neurol Sci 1995; 132 (2): 222-7.
27. Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999; 122 (7): 1341-1348.
28. Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006; 253 (8): 1054-9.
29. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76 (4): 469-75.
30. Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008; 15 (3): 239-45.
31. Da Silva AM, Vilhena E, Lopes A, Santos E, Gonçalves MA, Pinto C, et al. Depression and anxiety in a Portuguese MS population: Associations with physical disability and severity of disease. J Neurol Sci 2011; 306 (1-2): 66-70.
32. Suh Y, Motl RW, Mohr DC. Physical activity, disability, and mood in the early stage of multiple sclerosis. Disabil Health J 2010; 3 (2): 93-98.
33. Baumstarck-Barrau K, Simeoni MC, Reuter F, Klemina I, Aghababian V, Pelletier J, et al. Cognitive function and quality of life in multiple sclerosis patients: a crosssectional study. BMC Neurol 2011; 2: 11-17.
34. Siniscalchi A, Gallelli L, Tolotta GA, Loiacono D, De Sarro G. Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis. Clin Ther 2010; 32 (12): 2030-2034.
35. Patti F. Cognitive impairment in multiple sclerosis. Mult Scler 2009; 15 (1): 2-8.
36. DeSousa EA, Albert RH, Kalman B. Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen 2002; 17 (1): 23-9.
37. Patti F, Leone C, D'Amico E. Treatment options of cognitive impairment in multiple sclerosis. Neurol Sci 2010; 31: S265-9.